The PETITE-DTG study evaluated the dosing and safety of dolutegravir (DTG) in neonates born to mothers living with HIV. The study assessed a pediatric dispersible tablet and an oral film, finding the dosing strategy to be safe and effective. The PETITE PLATFORM aims to accelerate neonatal dosing recommendations for ARVs, with the goal of expanding access to the latest advancements in HIV care for newborns. The study showed high levels of acceptability for both DTG formulations, potentially improving HIV prevention and treatment options for neonates.
Full Article
Africa’s top shots: 15-21 August 2025
A selection of the week's best photos from across the African continent and beyond:Recent highlights include a model in Kenya promoting International Youth Day, South African climate activists protesting in Cape Town, and festivities celebrating Yoruba traditions in Nigeria. Additionally, significant cultural events featured musicians performing in the US and Tunisia, along with a stone artefact recovery in Alexandria. Want More Context? 🔎
Read more